Biotech Showcase 2023: Digital Medicine Innovation: Its Time is Now
Over the past three years, the importance and potential of digital healthcare technology have been brought to the forefront. What do investors seek in the next generation of digital healthcare products? In the 2023 Biotech Showcase, the panel, Digital Medicine Innovation: Its Time is Now, examines the current funding trends, showcases the stakeholders' knowledge in evaluating the value of digital therapeutics in healthcare, and delves into where investors are putting their focus. Three professionals broke away from the framework starting from a medical perspective and changed to a consumer and digital product developer perspective to find product positioning and implementation methods.
It's free! Log in now to read
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02